Mutations in the glucocerebrosidase gene are responsible for Chinese patients with Parkinson's disease

Journal of Human Genetics

Volumn 60, Issue 2, 2015, Pages 85-90

  Yu, Zhe ^a   Wang, Ting ^a   Xu, Jun ^a   Wang, Wei ^a   Wang, Guifang ^a   Chen, Chao ^a   Zheng, Lili ^a   Pan, Li ^a   Gong, Dianrong ^a   Li, Xueli ^a   Qu, Huaiqian ^a   Li, Fang ^b   Zhang, Bin ^a   Le, Weidong ^c   Han, Fabin ^a  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF OTTAWA   (Canada)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; GLUCOSYLCERAMIDASE;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA ISOLATION; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; ONSET AGE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PREDICTION; AMINO ACID SEQUENCE; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COHORT ANALYSIS; DNA MUTATIONAL ANALYSIS; ETHNOLOGY; GENE DELETION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SEQUENCE; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CHINA; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUCOSYLCERAMIDASE; HAPLOTYPES; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEQUENCE DELETION;

EID: 84926651755     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2014.110     Document Type: Article

References (30)

1. Zimprich, A., Benet-Pages, A., Struhal, W., Graf, E., Eck, S. H. & Offman, M. N. et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet. 89, 168-175 (2011).
2. Lill, C. M., Roehr, J. T., McQueen, M. B., Kavvoura, F. K., Bagade, S. & Schjeide, B. M. et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet. 8, e1002548 (2012).
3. Gasser, T. Molecular pathogenesis of Parkinson disease: Insights from genetic studies. Expert Rev. Mol. Med. 11, e22 (2009).
4. Grimes, D. A., Han, F., Panisset, M., Racacho, L., Xiao, F. & Zou, R. et al. Translated mutation in the Nurr1 gene as a cause for Parkinson's disease. Mov. Disord. 21, 906-909 (2006).
5. Beavan, M. S. & Schapira, A. H. Glucocerebrosidase mutations and the pathogenesis of Parkinson disease. Ann. Med. 45, 511-521 (2013).
6. Lwin, A., Orvisky, E., Goker-Alpan, O., LaMarca, M. E. & Sidransky, E. Glucocerebrosidase mutations in subjects with parkinsonism. Mol. Genet. Metab. 81, 70-73 (2004).
7. Lesage, S., Anheim, M., Condroyer, C., Pollak, P., Durif, F. & Dupuits, C. et al. Largescale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease. Hum. Mol. Genet. 20, 202-210 (2011).
8. Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G. & Barbosa, E. R. et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N. Engl. J. Med. 361, 1651-1661 (2009).
9. Hu, F. Y., Xi, J., Guo, J., Yu, L. H., Liu, L. & He, X. H. et al. Association of the glucocerebrosidase N370S allele with Parkinson's disease in two separate Chinese Han populations of mainland China. Eur. J. Neurol. 17, 1476-1478 (2010).
10. Sun, Q. Y., Guo, J. F., Wang, L., Yu, R. H., Zuo, X. & Yao, L. Y. et al. Glucocerebrosidase gene L444P mutation is a risk factor for Parkinson's disease in Chinese population. Mov. Disord. 25, 1005-1011 (2010).
11. Mao, X. Y., Burgunder, J. M., Zhang, Z. J., An, X. K., Zhang, J. H. & Yang, Y. et al. Association between GBA L444P mutation and sporadic Parkinson's disease from Mainland China. Neurosci. Lett. 469, 256-259 (2010).
12. Wang, Y., Liu, L., Xiong, J., Zhang, X., Chen, Z. & Yu, L. et al. Glucocerebrosidase L444P mutation confers genetic risk for Parkinson's disease in central China. Behav. Brain. Funct. 8, 57 (2012).
13. Hughes, A. J., Daniel, S. E. & Lees, A. J. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 57, 1497-1499 (2001).
14. Mitsui, J., Mizuta, I., Toyoda, A., Ashida, R., Takahashi, Y. & Goto, J. et al. Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch. Neurol. 66, 571-576 (2009).
15. Neumann, J., Bras, J., Deas, E., O'Sullivan, S. S., Parkkinen, L. & Lachmann, R. H. et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain 132, 1783-1794 (2009).
16. De Marco, E. V., Annesi, G., Tarantino, P., Rocca, F. E., Provenzano, G. & Civitelli, D. et al. Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy. Mov. Disord. 23, 460-463 (2008).
17. Clark, L. N., Ross, B. M., Wang, Y., Mejia-Santana, H., Harris, J. & Louis, E. D. et al. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology 69, 1270-1277 (2007).
18. Bras, J., Paisan-Ruiz, C., Guerreiro, R., Ribeiro, M. H., Morgadinho, A. & Januario, C. et al. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal. Neurobiol. Aging 30, 1515-1517 (2009).
19. Kalinderi, K., Bostantjopoulou, S., Paisan-Ruiz, C., Katsarou, Z., Hardy, J. & Fidani, L. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece. Neurosci. Lett. 452, 87-89 (2009).
20. Sato, C., Morgan, A., Lang, A. E., Salehi-Rad, S., Kawarai, T. & Meng, Y. et al. Analysis of the glucocerebrosidase gene in Parkinson's disease. Mov. Disord. 20, 367-370 (2005).
21. Tan, E. K., Tong, J., Fook-Chong, S., Yih, Y., Wong, M. C. & Pavanni, R. et al. Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients. Arch. Neurol. 64, 1056-1058 (2007).
22. Ziegler, S. G., Eblan, M. J., Gutti, U., Hruska, K. S., Stubblefield, B. K. & Goker-Alpan, O. et al. Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease. Mol. Genet. Metab. 91, 195-200 (2007).
23. Goker-Alpan, O., Lopez, G., Vithayathil, J., Davis, J., Hallett, M. & Sidransky, E. The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch. Neurol. 65, 1353-1357 (2008).
24. Gan-Or, Z., Giladi, N. & Orr-Urtreger, A. Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations. Brain 132, e125 (2009).
25. Eblan, M. J., Nguyen, J., Ziegler, S. G., Lwin, A., Hanson, M. & Gallardo, M. et al. Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela. Mov. Disord. 21, 282-283 (2006).
26. Segarane, B., Li, A., Paudel, R., Scholz, S., Neumann, J. & Lees, A. et al. Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology 72, 1185-1186 (2009).
27. Farrer, M. J., Williams, L. N., Algom, A. A., Kachergus, J., Hulihan, M. M. & Ross, O. A. et al. Glucosidase-beta variations and Lewy body disorders. Parkinsonism Relat. Disord. 15, 414-416 (2009).
28. Tsuang, D., Leverenz, J. B., Lopez, O. L., Hamilton, R. L., Bennett, D. A. & Schneider, J. A. et al. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology 79, 1944-1950 (2012).
29. Cullen, V., Sardi, S. P., Ng, J., Xu, Y. H., Sun, Y. & Tomlinson, J. J. et al. Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha-synuclein processing. Ann. Neurol. 69, 940-953 (2011).
30. Ron, I. & Horowitz, M. ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity. Hum. Mol. Genet. 14, 2387-2398 (2005).